Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Seubert

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 16, 2013
Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalitiesWagner Zago, Sally Schroeter, Teresa Guido, et al.
Neuron|June 15, 2005
Effects of alpha-synuclein immunization in a mouse model of Parkinson's diseaseEliezer Masliah, Edward Rockenstein, Anthony Adame, et al.
Neuro-Degenerative Diseases|January 10, 2008
Red blood cells are the major source of alpha-synuclein in bloodRobin Barbour, Kristin Kling, John P Anderson, et al.
Frontiers in Immunology|May 9, 2012
Generation and characterization of anti-AA amyloid-specific monoclonal antibodiesJonathan S Wall, Stephen J Kennel, Tina Richey, et al.
Acta Neuropathologica Communications|March 27, 2026
Retraction Note: Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathyBrian Spencer, Elvira Valera, Edward Rockenstein, et al.
Acta Neuropathologica Communications|January 15, 2017
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathyBrian Spencer, Elvira Valera, Edward Rockenstein, et al.
Journal of Neuropathology and Experimental Neurology|November 7, 2006
Abeta species removal after abeta42 immunizationJames A R Nicoll, Edward Barton, Delphine Boche, et al.
Biochemistry|May 21, 2014
Secreted amyloid β-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticityAlfred T Welzel, John E Maggio, Ganesh M Shankar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2014
Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like modelsDora Games, Elvira Valera, Brian Spencer, et al.
Neuro-Degenerative Diseases|January 10, 2008
Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mousePeter Seubert, Robin Barbour, Karen Khan, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 16, 2013
Vascular alterations in PDAPP mice after anti-Aβ immunotherapy: Implications for amyloid-related imaging abnormalitiesWagner Zago, Sally Schroeter, Teresa Guido, et al.
Neuron|June 15, 2005
Effects of alpha-synuclein immunization in a mouse model of Parkinson's diseaseEliezer Masliah, Edward Rockenstein, Anthony Adame, et al.
Neuro-Degenerative Diseases|January 10, 2008
Red blood cells are the major source of alpha-synuclein in bloodRobin Barbour, Kristin Kling, John P Anderson, et al.
Frontiers in Immunology|May 9, 2012
Generation and characterization of anti-AA amyloid-specific monoclonal antibodiesJonathan S Wall, Stephen J Kennel, Tina Richey, et al.
Acta Neuropathologica Communications|March 27, 2026
Retraction Note: Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathyBrian Spencer, Elvira Valera, Edward Rockenstein, et al.
Acta Neuropathologica Communications|January 15, 2017
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathyBrian Spencer, Elvira Valera, Edward Rockenstein, et al.
Journal of Neuropathology and Experimental Neurology|November 7, 2006
Abeta species removal after abeta42 immunizationJames A R Nicoll, Edward Barton, Delphine Boche, et al.
Biochemistry|May 21, 2014
Secreted amyloid β-proteins in a cell culture model include N-terminally extended peptides that impair synaptic plasticityAlfred T Welzel, John E Maggio, Ganesh M Shankar, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 11, 2014
Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like modelsDora Games, Elvira Valera, Brian Spencer, et al.
Neuro-Degenerative Diseases|January 10, 2008
Antibody capture of soluble Abeta does not reduce cortical Abeta amyloidosis in the PDAPP mousePeter Seubert, Robin Barbour, Karen Khan, et al.
Pageof 4